Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
Thibault LhermusierDidier CarrieGuillaume CaylaJean FajadetJoel SainsousSimon ElhadadFrancois TarraganoBernard ChevalierSylvain RancCorentin CurinierHerve Le BretonRene Koningnull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Although 3-year mortality was low in this ACS population, device-related events were significant beyond 1 year. Total BVS length and 2.5 mm BVS were associated with higher rates of MACE at long-term follow-up.